{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaxo4kiu655f7yyq43yoa7x4xiscuxgzcszps3fpya4oqsjhtkvwi",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfshgtnujfn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicsddjwf55umufmv2pia72adspgux77huuwoqpi5syg5ldaduhpqm"
    },
    "mimeType": "image/jpeg",
    "size": 250964
  },
  "path": "/news/2026-02-utero-stem-cell-therapy-fetal.html",
  "publishedAt": "2026-02-26T18:30:03.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Pediatrics"
  ],
  "textContent": "A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of spina bifida. This is the first time live stem cells have been used on a fetus's damaged spine, which could potentially lead to better health outcomes for babies compared to traditional fetal surgery.",
  "title": "First-ever in-utero stem cell therapy for fetal spina bifida repair shows safe results"
}